Ann: Bisantrene Phase 2 AML Trial Successful Concludes, page-47

...we are maybe 12 months away from confirmation of the first drug to ever protect the heart from while more effectively killing cancer with cardiotoxic chemotherapy. In 60+ years of drug discovery and possibly millions of compounds put to the test, there is one that effectively translates to humans to treat cancer while having off target protective effects that just happens to mitigate the most studied toxicity in history. That same drug also happens to have been shown to be safe in 1700+ people and was as effective as doxorubicin in a p3 trial with better safety. While the activity is certainly pleiotropic, the most potent mechanism of action is a completely novel area of therapy shown to be the root cause of therapy resistance and relapse.

Honestly, man, I have 0 idea what you are talking about regarding timing and opportunity. The time to establish and solidify your position is now.